228 related articles for article (PubMed ID: 31580514)
21. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
Lubel JS; Herath CB; Tchongue J; Grace J; Jia Z; Spencer K; Casley D; Crowley P; Sievert W; Burrell LM; Angus PW
Clin Sci (Lond); 2009 Sep; 117(11):375-86. PubMed ID: 19371232
[TBL] [Abstract][Full Text] [Related]
23. Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.
Lin H; Geurts F; Hassler L; Batlle D; Mirabito Colafella KM; Denton KM; Zhuo JL; Li XC; Ramkumar N; Koizumi M; Matsusaka T; Nishiyama A; Hoogduijn MJ; Hoorn EJ; Danser AHJ
Pharmacol Rev; 2022 Jul; 74(3):462-505. PubMed ID: 35710133
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
Wolf G; Ritz E
Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
[TBL] [Abstract][Full Text] [Related]
25. Translational studies on augmentation of intratubular renin-angiotensin system in hypertension.
Navar LG
Kidney Int Suppl (2011); 2013 Dec; 3(4):321-325. PubMed ID: 25019012
[TBL] [Abstract][Full Text] [Related]
26. Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells.
Zhang SL; To C; Chen X; Filep JG; Tang SS; Ingelfinger JR; Carrière S; Chan JS
Exp Nephrol; 2001; 9(2):109-17. PubMed ID: 11150859
[TBL] [Abstract][Full Text] [Related]
27. The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation.
Hartl L; Rumpf B; Domenig O; Simbrunner B; Paternostro R; Jachs M; Poglitsch M; Marculescu R; Trauner M; Reindl-Schwaighofer R; Hecking M; Mandorfer M; Reiberger T
Sci Rep; 2023 Jan; 13(1):953. PubMed ID: 36653504
[TBL] [Abstract][Full Text] [Related]
28. Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data.
Sansoè G; Aragno M; Mastrocola R; Mengozzi G; Novo E; Parola M
PLoS One; 2016; 11(9):e0162644. PubMed ID: 27637026
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II.
Shaltout HA; Westwood BM; Averill DB; Ferrario CM; Figueroa JP; Diz DI; Rose JC; Chappell MC
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F82-91. PubMed ID: 16896185
[TBL] [Abstract][Full Text] [Related]
30. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk between the renal sympathetic nerve and intrarenal angiotensin II modulates proximal tubular sodium reabsorption.
Pontes RB; Girardi AC; Nishi EE; Campos RR; Bergamaschi CT
Exp Physiol; 2015 Apr; 100(5):502-6. PubMed ID: 25858030
[TBL] [Abstract][Full Text] [Related]
32. Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system.
Hollenberg NK; Fisher ND; Price DA
Hypertension; 1998 Sep; 32(3):387-92. PubMed ID: 9740600
[TBL] [Abstract][Full Text] [Related]
33. N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
Li S; Li Y; Zhang Y; Li S; Zhang M; Jin F; Wei Z; Yang Y; Gao X; Mao N; Ge X; Xu H; Yang F
Toxicol Appl Pharmacol; 2020 Dec; 408():115255. PubMed ID: 33007385
[TBL] [Abstract][Full Text] [Related]
34. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
Azizi M
Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
[TBL] [Abstract][Full Text] [Related]
35. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
36. [The renin-angiotensin-aldosterone system -- more complex as previously thought].
Wolf G
Med Klin (Munich); 2005 Aug; 100(8):471-7. PubMed ID: 16096728
[TBL] [Abstract][Full Text] [Related]
37. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats.
Cervenka L; Wang CT; Mitchell KD; Navar LG
Hypertension; 1999 Jan; 33(1):102-7. PubMed ID: 9931089
[TBL] [Abstract][Full Text] [Related]
38. Liver fibrosis: a balance of ACEs?
Warner FJ; Lubel JS; McCaughan GW; Angus PW
Clin Sci (Lond); 2007 Aug; 113(3):109-18. PubMed ID: 17600527
[TBL] [Abstract][Full Text] [Related]
39. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.
Grace JA; Herath CB; Mak KY; Burrell LM; Angus PW
Clin Sci (Lond); 2012 Aug; 123(4):225-39. PubMed ID: 22548407
[TBL] [Abstract][Full Text] [Related]
40. Role of Collecting Duct Renin in the Pathogenesis of Hypertension.
Gonzalez AA; Lara LS; Prieto MC
Curr Hypertens Rep; 2017 Aug; 19(8):62. PubMed ID: 28695400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
